| 摘要 |
<p>"Therapeutic method for the treatment of juvenile diabetes mellitus and pharmaceutical composition for such a method". S The oral or parenteral administration of L-carnitine or certain L-acyl carnitines, typically L-propionyl carnitine, or the pharmacological salts thereof, permits a considerable reduction (from 20 to approx. 50%) of the daily dose of insulin that should be administered to patients affected by juvenile diabetes mellitus to restore normal blood glucose levels. Moreover, L-carnitine and such acyl carnitines actively inhibit ketoacidosis, thus avoiding the risk of ketoacidosic coma in such patients.</p> |
